What pharmaceutical form is HealthdirectFree Australian health advice you can count on. available in?

HealthdirectFree Australian health advice you can count on.: CAPSULE 150 mg/1 (ORAL)

What are the side effects of HealthdirectFree Australian health advice you can count on.?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can HealthdirectFree Australian health advice you can count on. be used during pregnancy?

( AHT ) For the active ingredient thalidomide This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.

What precautions should be taken with HealthdirectFree Australian health advice you can count on.?

• Caution should be exercised in patients with history of human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), decrease in white blood cells, seizures, and in children. • It may cause dizziness or drowsiness, do not drive a car or operate machinery and get up slowly from bed while taking this medication. • Avoid alcohol consumption while taking this medication.

HealthdirectFree Australian health advice you can count on.

This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.

( ARTG ) MULTIPLE MYELOMA - Thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years and over or ineligible for high dose chemotherapy.‍‍‍‍‍‍‍ Thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. Thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies. ERYTHEMA NODOSUM LEPROSUM (ENL). Thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Thalomid is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. Thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.MULTIPLE MYELOMA - Thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years and over or ineligible for high dose chemotherapy. Thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. Thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies. ERYTHEMA NODOSUM LEPROSUM (ENL). Thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Thalomid is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. Thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence. Thalomid is prescribed and dispensed through the Thalidomide Risk Management Programme.

HealthdirectFree Australian health advice you can count on.

User Reviews